These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 29735783

  • 1. Antiproliferative Effects of Epigenetic Modifier Drugs Through E-cadherin Up-regulation in Liver Cancer Cell Lines.
    Uribe D, Cardona A, Esposti DD, Cros MP, Cuenin C, Herceg Z, Camargo M, Cortés-Mancera FM.
    Ann Hepatol; 2018; 17(3):444-460. PubMed ID: 29735783
    [Abstract] [Full Text] [Related]

  • 2. Genetic and epigenetic inactivation of T-cadherin in human hepatocellular carcinoma cells.
    Chan DW, Lee JM, Chan PC, Ng IO.
    Int J Cancer; 2008 Sep 01; 123(5):1043-52. PubMed ID: 18553387
    [Abstract] [Full Text] [Related]

  • 3. Integrative analysis of aberrant Wnt signaling in hepatitis B virus-related hepatocellular carcinoma.
    Ding SL, Yang ZW, Wang J, Zhang XL, Chen XM, Lu FM.
    World J Gastroenterol; 2015 May 28; 21(20):6317-28. PubMed ID: 26034368
    [Abstract] [Full Text] [Related]

  • 4. Change in gene expression profiles of secreted frizzled-related proteins (SFRPs) by sodium butyrate in gastric cancers: induction of promoter demethylation and histone modification causing inhibition of Wnt signaling.
    Shin H, Kim JH, Lee YS, Lee YC.
    Int J Oncol; 2012 May 28; 40(5):1533-42. PubMed ID: 22246241
    [Abstract] [Full Text] [Related]

  • 5. Concurrent epigenetic silencing of wnt/β-catenin pathway inhibitor genes in B cell chronic lymphocytic leukaemia.
    Moskalev EA, Luckert K, Vorobjev IA, Mastitsky SE, Gladkikh AA, Stephan A, Schrenk M, Kaplanov KD, Kalashnikova OB, Pötz O, Joos TO, Hoheisel JD.
    BMC Cancer; 2012 Jun 06; 12():213. PubMed ID: 22672427
    [Abstract] [Full Text] [Related]

  • 6. Epigenetic silencing of BCL6B inactivates p53 signaling and causes human hepatocellular carcinoma cell resist to 5-FU.
    Li X, Yu J, Brock MV, Tao Q, Herman JG, Liang P, Guo M.
    Oncotarget; 2015 May 10; 6(13):11547-60. PubMed ID: 25909168
    [Abstract] [Full Text] [Related]

  • 7. Effect of trichostatin A on anti HepG2 liver carcinoma cells: inhibition of HDAC activity and activation of Wnt/β-Catenin signaling.
    Shi QQ, Zuo GW, Feng ZQ, Zhao LC, Luo L, You ZM, Li DY, Xia J, Li J, Chen DL.
    Asian Pac J Cancer Prev; 2014 May 10; 15(18):7849-55. PubMed ID: 25292076
    [Abstract] [Full Text] [Related]

  • 8. Epigenetic combination therapy as a tumor-selective treatment approach for hepatocellular carcinoma.
    Venturelli S, Armeanu S, Pathil A, Hsieh CJ, Weiss TS, Vonthein R, Wehrmann M, Gregor M, Lauer UM, Bitzer M.
    Cancer; 2007 May 15; 109(10):2132-41. PubMed ID: 17407132
    [Abstract] [Full Text] [Related]

  • 9. Downregulation of SFRP1 is a protumorigenic event in hepatoblastoma and correlates with beta-catenin mutations.
    Regel I, Eichenmüller M, Mahajan UM, Hagl B, Benitz S, Häberle B, Vokuhl C, von Schweinitz D, Kappler R.
    J Cancer Res Clin Oncol; 2020 May 15; 146(5):1153-1167. PubMed ID: 32189106
    [Abstract] [Full Text] [Related]

  • 10. The TCF4/β-catenin pathway and chromatin structure cooperate to regulate D-glucuronyl C5-epimerase expression in breast cancer.
    Mostovich LA, Prudnikova TY, Kondratov AG, Gubanova NV, Kharchenko OA, Kutsenko OS, Vavilov PV, Haraldson K, Kashuba VI, Ernberg I, Zabarovsky ER, Grigorieva EV.
    Epigenetics; 2012 Aug 15; 7(8):930-9. PubMed ID: 22805760
    [Abstract] [Full Text] [Related]

  • 11. The role of E-cadherin down-regulation in oral cancer: CDH1 gene expression and epigenetic blockage.
    Pannone G, Santoro A, Feola A, Bufo P, Papagerakis P, Lo Muzio L, Staibano S, Ionna F, Longo F, Franco R, Aquino G, Contaldo M, De Maria S, Serpico R, De Rosa A, Rubini C, Papagerakis S, Giovane A, Tombolini V, Giordano A, Caraglia M, Di Domenico M.
    Curr Cancer Drug Targets; 2014 Aug 15; 14(2):115-27. PubMed ID: 24274398
    [Abstract] [Full Text] [Related]

  • 12. Genome-wide transcriptional response to 5-aza-2'-deoxycytidine and trichostatin a in multiple myeloma cells.
    Heller G, Schmidt WM, Ziegler B, Holzer S, Müllauer L, Bilban M, Zielinski CC, Drach J, Zöchbauer-Müller S.
    Cancer Res; 2008 Jan 01; 68(1):44-54. PubMed ID: 18172295
    [Abstract] [Full Text] [Related]

  • 13. Transcriptional silencing of the TMS1/ASC tumour suppressor gene by an epigenetic mechanism in hepatocellular carcinoma cells.
    Zhang C, Li H, Zhou G, Zhang Q, Zhang T, Li J, Zhang J, Hou J, Liew CT, Yin D.
    J Pathol; 2007 Jun 01; 212(2):134-42. PubMed ID: 17471463
    [Abstract] [Full Text] [Related]

  • 14. The epigenetically regulated effects of Wnt antagonists on the expression of genes in the apoptosis pathway in human bladder cancer cell line (T24).
    Varol N, Konac E, Onen IH, Gurocak S, Alp E, Yilmaz A, Menevse S, Sozen S.
    DNA Cell Biol; 2014 Jul 01; 33(7):408-17. PubMed ID: 24665856
    [Abstract] [Full Text] [Related]

  • 15. Reduced T-cadherin expression and promoter methylation are associated with the development and progression of hepatocellular carcinoma.
    Yan Q, Zhang ZF, Chen XP, Gutmann DH, Xiong M, Xiao ZY, Huang ZY.
    Int J Oncol; 2008 May 01; 32(5):1057-63. PubMed ID: 18425332
    [Abstract] [Full Text] [Related]

  • 16. Alterations of Wnt/β-catenin signaling pathway in hepatocellular carcinomas associated with hepatitis C virus.
    Rogacki K, Kasprzak A, Stępiński A.
    Pol J Pathol; 2015 Mar 01; 66(1):9-21. PubMed ID: 26017875
    [Abstract] [Full Text] [Related]

  • 17. Epigenetic Activation of Cytochrome P450 1A2 Sensitizes Hepatocellular Carcinoma Cells to Sorafenib.
    Zhang Y, Feng J, Mi Y, Fan W, Qin R, Mei Y, Jin G, Mao J, Zhang H.
    Drug Metab Dispos; 2024 May 16; 52(6):555-564. PubMed ID: 38565301
    [Abstract] [Full Text] [Related]

  • 18. DACT3 is an epigenetic regulator of Wnt/beta-catenin signaling in colorectal cancer and is a therapeutic target of histone modifications.
    Jiang X, Tan J, Li J, Kivimäe S, Yang X, Zhuang L, Lee PL, Chan MT, Stanton LW, Liu ET, Cheyette BN, Yu Q.
    Cancer Cell; 2008 Jun 16; 13(6):529-41. PubMed ID: 18538736
    [Abstract] [Full Text] [Related]

  • 19. Hepatitis C virus core protein epigenetically silences SFRP1 and enhances HCC aggressiveness by inducing epithelial-mesenchymal transition.
    Quan H, Zhou F, Nie D, Chen Q, Cai X, Shan X, Zhou Z, Chen K, Huang A, Li S, Tang N.
    Oncogene; 2014 May 29; 33(22):2826-35. PubMed ID: 23770846
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of the Wnt/β-catenin signaling pathway improves the anti-tumor effects of sorafenib against hepatocellular carcinoma.
    Lin HH, Feng WC, Lu LC, Shao YY, Hsu CH, Cheng AL.
    Cancer Lett; 2016 Oct 10; 381(1):58-66. PubMed ID: 27431312
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.